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ABSTRACT
Initiation of DNA replication depends upon recog-
nition of genomic sites, termed origins, by AAA+
ATPases. In prokaryotes a single factor binds each
origin, whereas in eukaryotes this role is played
by a six-protein origin recognition complex (ORC).
Why eukaryotes evolved a multisubunit initiator, and
the roles of each component, remains unclear. In
Trypanosoma brucei, an ancient unicellular eukary-
ote, only one ORC-related initiator, TbORC1/CDC6,
has been identified by sequence homology. Here
we show that three TbORC1/CDC6-interacting fac-
tors also act in T. brucei nuclear DNA replication
and demonstrate that TbORC1/CDC6 interacts in a
high molecular complex in which a diverged Orc4
homologue and one replicative helicase subunit can
also be found. Analysing the subcellular localization
of four TbORC1/CDC6-interacting factors during the
cell cycle reveals that one factor, TbORC1B, is not
a static constituent of ORC but displays S-phase
restricted nuclear localization and expression, sug-
gesting it positively regulates replication. This work
shows that ORC architecture and regulation are di-
verged features of DNA replication initiation in T. bru-
cei, providing new insight into this key stage of eu-
karyotic genome copying.
INTRODUCTION
Genome transmission is central to life and requires replica-
tion to generate new genome copies, which are then passed
to progeny. In all cellular organisms DNA replication is ini-
tiated at genomic sites termed origins, which are bound by
initiator factors. Binding of initiators allows recruitment
and activation of the replicative helicase, which leads to
opening of the originDNA, recruitment of the remainder of
the replication machinery and initiation of DNA synthesis
(1–3). Though all initiators appear related, in that they be-
long to the AAA+ superfamily of NTPases (4,5), their func-
tional architecture differs between prokaryotes and eukary-
otes. In prokaryotes an origin is bound by a single initiator
protein, which in bacteria oligomerises during recruitment
of the replicative helicase. In contrast, and for reasons that
remain unclear, the origin-binding initiator has evolved into
a multiprotein complex in eukaryotes.
Eukaryotic genomes contain many origins of replication,
each recognized by a conserved six-subunit origin recogni-
tion complex (ORC) (6). Like prokaryotic initiator factors
(DnaA in bacteria and Orc1/Cdc6 in archea) (7,8), five of
the six subunits of eukaryotic ORC (Orcs1–5, but not Orc6)
belong to the DnaA/CDC6/ORC clade of the AAA+ su-
perfamily of ATPases (9). Once ORC is bound to an ori-
gin, Cdc6 (Cell Division Cycle 6), another AAA+ ATPase
and a paralogue of Orc1 (6,10), is recruited. Cdc6 bind-
ing induces conformational changes in ORC (11) that sta-
bilize ORC-origin interaction (12) and allow recruitment,
mediated by Cdt1 (13–15), of the heterohexamericMCM2–
7 replicative helicase (16). All six minichromosome mainte-
nance (MCM) subunits are also AAA+ ATPases (17), and
the structure formed by MCM2–7-Cdt1-Cdc6-ORC inter-
action is termed the pre-replication complex (pre-RC). For-
mation of the pre-RC at origins takes place from mitosis to
late G1 phase of the cell cycle and is known as origin licens-
ing (1,2).
ORC was first purified from Saccharomyces cerevisiae
(18). Subsequently, ORCs were identified in Xenopus lae-
vis (19), Drosophila melanogaster (20) and Schizosaccha-
romyces pombe (21), and characterization of the subunits
revealed their conservation with S. cerevisiae and in many
other eukaryotes, including mammals (6). Orcs1–5 and
Cdc6 share a common structure: each contains a central
or N-terminal AAA+ ATPase domain and, downstream,
a winged helix (WH) domain that, together, mediate DNA
binding (22–24). Most eukaryotic Orc1 subunits possess N-
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terminal homology with Sir3, including a bromo-adjacent
homology (BAH) domain (25), which underlies Orc1’s role
in transcriptional silencing (26,27). Orc6 appears to be un-
related to the other ORC subunits (28), lacking discernible
AAA+ homology (6), though structural studies have re-
vealed homology between the N-terminus of metazoan
Orc6 and the transcription factor TFIIB (29), which may
contribute to DNA binding (30). Structural analysis by
electron microscopy (EM) and, recently, by crystallography
has revealed the order of Orc subunit interaction within
ORC, as well as how Cdc6 directs recruitment of Cdt1-
MCM2–7 in the pre-RC (11,22,31–33). The broadly con-
served EM-derived structures of ORC from S. cerevisiae
(34) andD. melanogaster (35) are consistent with interlock-
ing of the AAA+ and WH domains of the Orc subunits
being central to the function of the complex (22). Such in-
terlocking is likely to be the basis for the conformational
changes associated with ORC assembly and DNA inter-
action, which are due to ATP binding and hydrolysis by
the Orc subunits (22,33,36). Indeed, these ATP-driven con-
formational changes extend beyond ORC, with the AT-
Pase activity of Cdc6 further changing ORC structure and
modulating interaction with the other pre-RC components
(11,12,32,37,38). Despite this, it remains unclear why six
AAA+ ATPases factors are needed for ORC-Cdc6 func-
tion, and what function each ORC subunit provides. In ar-
chaea the MCM replicative helicase is also hexameric (39)
but is recruited to an origin by a single protein, termed
Orc1/Cdc6, which is related to both eukaryotic Orc1 and
Cdc6 and fulfils the functions of the two proteins (40). Ar-
chaeal Orc1/Cdc6 proteins use ATPase activity and co-
operative interactions betweenmonomers to distort the ori-
gin DNA (23,24,41), suggesting broad functional similar-
ity to eukaryotic ORC-Cdc6. Why there is such an appar-
ent gulf between the architectures of archaeal and eukary-
otic initiators is unclear, in particular because growing evi-
dence suggests that eukaryotes arose from an archaeal an-
cestor(42).
To date, ORC architecture has only been explored in
the opisthokont supergroup of eukaryotes, which includes
yeast, D. melanogaster and mammals. Relatively little work
has examined DNA replication in protists, a vast group-
ing of unicellular eukaryotic microbes that provides most of
the diversity in the eukaryotic domain (43–45). In Tetrahy-
mena thermophila, a multisubunit ORC complex has been
described, some of whose components are related to the
canonical eukaryotic subunits, but the overall architec-
ture remains unresolved (46,47). Homology searches reveal
that it is surprisingly difficult to identify homologues of
all six Orc subunits, or Cdc6, in many eukaryotic organ-
isms belonging to the non-opisthokont supergroups (48,49).
Whether this is because of lineage-specific gene losses from
an ancestral six subunit ORC-Cdc6 organization (50), or if
the opisthokont initiation machinery may not be as univer-
sal in eukaryotes as anticipated, is currently unclear.
The kinetoplastida is a well-studied order of eukary-
otic microbes that belongs to the excavata supergroup (51)
and contains a number of important human and animal
parasites, such as Trypanosoma brucei. Genome sequenc-
ing of T. brucei and related kinetoplastid parasites iden-
tified only a single ORC-related protein (52), which con-
tains well-conserved AAA+ ATPase motifs and some ev-
idence of a C-terminal WH domain (53), but lacks N-
terminal sequences found in other eukaryotic Orc1 sub-
units, including the BAH domain. The structural similarity
of this protein to Orc1/Cdc6 in archaea has led to adoption
of the name ORC1/CDC6, an analogy that may be sup-
ported functionally by the ability of T. bruceiORC1/CDC6
(TbORC1/CDC6) to complement S. cerevisiae cdc6 tem-
perature sensitive mutants (53). TbORC1/CDC6 has been
shown to act in T. brucei nuclear DNA replication, both
through impairment of nucleotide analogue incorporation
after RNA interference (RNAi) (54) and localization of the
protein at mapped replication origins in the genome (55). A
number of TbORC1/CDC6-interacting factors have subse-
quently been identified, raising the possibility that an ORC
is present. However, many of the TbORC1/CDC6 interac-
tors are highly diverged in sequence from canonical ORC
subunits (49) and none has been shown to have a role in
replication. One such factor has been named TbORC1B,
based on its identification by weak homology with Orc1
and the presence of AAA+ ATPase motifs (56). Amongst
three further TbORC1/CDC6 interactors (49), one (named
TbORC4) appears to be a distant orthologue of Orc4, while
the two others (Tb3120 and Tb7980), though displaying
weak evidence for ATPase motifs, cannot be assigned ORC
subunit orthology because primary sequence-based homol-
ogy searches reveal only kinetoplastid homologues (49).
Here, we show that TbORC1B, TbORC4 and Tb3120 all
act in nuclear DNA replication, and provide evidence that
TbORC1/CDC6 and TbORC4 are present in a high molec-
ular complex in the parasite, suggesting the presence of a
diverged ORC. Within this complex we can also detect the
helicase subunit TbMCM3, suggesting the presence of a sta-
ble pre-RC-like complex. By examining the subcellular lo-
calization of all currently identified TbORC1/CDC6 inter-
acting factors, we show that TbORC1B is not a static com-
ponent of theT. bruceiORC and instead shows S-phase lim-
ited expression, suggesting that this Orc1-like factor adopts
an unorthodox, positive regulatory role in T. brucei nuclear
DNA replication.
MATERIALS AND METHODS
Trypanosoma brucei strains, growth and transformation
Trypanosoma brucei procyclic form (PCF) cells, strain Lis-
ter 427 pLew29-pLew13 (57), were used for RNAi assays,
while PCF TREU 927 cells were used for endogenous epi-
tope tagging, microscopy, immunoprecipitation and gel fil-
tration assays. TREU927 cells expressing TbORC1/CDC6
endogenously tagged with 12myc at the C-terminus and
with the remaining TbORC1/CDC6 allele deleted, as well
as expressing TbMCM3 endogenously tagged with 6HA,
have been described previously (49). PCF cells were cul-
tured in SDM-79 (Gibco) supplemented with 10% (v/v)
heat-inactivated fetal bovine serum (FBS, Sigma-Aldrich),
1% (v/v) penicillin-streptomycin solution (Gibco), and 5
g.ml−1 of haemin (Sigma-Aldrich), at 27◦C, in non-vented
flasks. Whenever required, the medium was supplemented
with the appropriate selective drugs as follows: 50 g.ml−1
of hygromycin; 10 g.ml−1 of G418, zeocin or blasticidin; 1
g.ml−1 of puromycin (all InvivoGen). Bloodstream form
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(BSF) Lister 427 cells were used for endogenous tagging
and subcellular localization by microscopy, and cultured in
HMI-9 (Gibco) supplemented with 20% (v/v) FBS (Sigma-
Aldrich) and 1% (v/v) of penicillin-streptomycin solution
(Gibco). For RNAi, BSF Lister 427 cells, strain 2T1 (58),
were used. BSF cells were routinely maintained in HMI-11
medium, composed of HMI-9 medium supplemented with
10% (v/v) FBS (Sigma-Aldrich), and 1% (v/v) of penicillin-
streptomycin solution (Gibco); when assaying EdU up-
take, however, the cells were cultured in HMI-11 thymidine-
free medium consisting of Iscove’s Modified Dulbecco’s
Medium (IMDM) (Gibco), 10% (v/v) FBS (Gibco, tetra-
cycline free), 1% (v/v) penicillin-streptomycin solution
(Gibco), 4% (v/v) HMI-9 mix (0.05 mM of bathocuproine
disulphonic acid, 1 mM of sodium pyruvate and 1.5 mM of
L-cysteine) (Sigma Aldrich), 1 mM hypoxanthine (Sigma
Aldrich) and 0.0014% 2-mercaptoethanol (Sigma Aldrich).
In all cases, BSF cells were incubated at 37◦C and 5%
CO2 in vented flasks. Whenever required, the medium
was supplemented with the appropriate selective drugs as
follows: 5 g.ml−1 of hygromycin; 2.5 g.ml−1 of G418
or phleomycin; 10 g.ml−1 of blasticidin; 0.2 g.ml−1 of
puromycin (all InvivoGen). Both PCF cells and BSF cells
were transformed as described elsewhere (49).
Endogenous epitope tagging
TbORC1B, TbORC4 and Tb3120 were endogenously
tagged, at the C-terminus, with 12 copies of c-myc
(12myc) using constructs derived from the pNAT12M plas-
mid (58), as described previously (49). The 3′ end of
the ORF of the gene of interest, with the exclusion
of the stop codon, was PCR-amplified using the fol-
lowing primers: TbORC1B, GCATAAGCTTACAACG
AGACAGTCAAATCG and GCATTCTAGACAGGGA
TAAAATGCCCTTGA; TbORC4, CCCAAGCTTCGT
TTCTGCTGTCTTTGGGG and CCCTCTAGACACGA
GGCTGCGTAATC; Tb3120, CCCAAGCTTAGTGCAT
GGTATAGACGAA and CCCTCTAGATGCCTCCAC
TGGAGCTCCAC. In each case, the forward primer con-
tained a HindIII restriction site, while the reverse contained
an XbaI site, allowing cloning of each gene fragment into
pNAT12M. The resulting plasmids were linearized prior to
transfection into either PCF or BSF cells, using the follow-
ing restriction enzymes: ClaI (TbORC1B), SmaI (TbORC4)
or NsiI (Tb3120). For tagging of TbORC1/CDC6 the
construct generated in (49) was used. Transformant PCF
cells were selected with 15 g.ml−1 blasticidin, while
BSF cells were selected with 10 g.ml−1 blasticidin.
Tb7980 was endogenously tagged with 12myc at the N-
terminus using a construct modified from the pEnT6B
plasmid (59). In this case, two fragments were PCR-
amplified: the 5′ end of the Tb7980 ORF (excluding the
start codon), using the primers GCATACTAGTGCAG
CCCAAACACCACGCA (containing the SpeI restriction
site) and GCATGGTACCCACGACGAAGTGAAGCTC
A (containing the NotI site); and a section from the
5′ intergenic region upstream of the Tb7980 ORF, us-
ing the primers GCATGGTACCGACATGCCGTGACG
AACTC (containing the KpnI site) and GCATGGATCC
ACGACGGGGAAACAGAACG (containing the BamHI
site). The resulting plasmid was then linearized (NotI) prior
to transfection into either PCF or BSF cells. Transformant
cells were selected with 15 g.ml−1 blasticidin (PCFs) or 10
g.ml−1 blasticidin (BSFs).
RNA interference analysis in PCF cells
For RNAi analysis in PCF cells, a modified version of
the stem-loop pLew111 construct (60) containing the
BLE resistance marker, and a fragment of the human
PLK1 gene within the HindIII/BamHI linker was used.
This construct encloses two cloning sites, HindIII/XhoI
and AflII/BamHI, which allow the sequential insertion,
in a head-to-head configuration, of two identical PCR
products, each flanked with one of the two different re-
striction site combinations. The region of each gene to be
PCR-amplified (sizes between 400 and 600 bp), as well as
the best pair of primers to use, was chosen using RNAit
(http://trypanofan.bioc.cam.ac.uk/software/RNAit.html).
For each gene, two identical fragments were PCR-amplified
using the two sets of primers, so that one PCR fragment
(inserted into the plasmid in the sense orientation) was
flanked by the HindIII and XhoI restriction sites, while
the other (inserted into the plasmid in the anti-sense
orientation) was flanked by the BamHI and AflII sites. The
following primers were used: TbORC1/CDC6––CC
CCAAGCTTGAAGCCCACAGCTGTCTTTC,
CCCCCTCGAGTTCTCCGGCAACTTGTAACC,
CCCCGGATCCGAAGCCCACAGCTGTCTTTC and
CCCCCTTAAGTTCTCCGGCAACTTGTAACC;
TbORC4––CCCCAAGCTTCACGTTGTATCCCCTT
GCTT, CCCCCTCGAGTTCAGTTTCGGCGAAGTT
CT, CCCCGGATCCCACGTTGTATCCCCTTGCTT
and CCCCCTTAAGTTCAGTTTCGGCGAAGTTCT;
TbORC1B––CCCCAAGCTTCTATCGGCTGAGTACG
CCTC, CCCCCTCGAGTTTGCGATTTGACTGTCT
CG, CCCCGGATCCCTATCGGCTGAGTACGCCTC
and CCCCCTTAAGTTTGCGATTTGACTGTCTCG;
Tb3120––CCCCAAGCTTCTAACGGCTCAGTTTCTC
GG, CCCCCTCGAGTTGGCAAAAGATTCCTCACC,
CCCCGGATCCCTAACGGCTCAGTTTCTCGG and
CCCCCTTAAGTTGGCAAAAGATTCCTCACC. The
two PCR products were sequentially cloned into the
vector, and the resulting constructs were subsequently
linearised with NotI and transfected into PCF 29–13
cells. Transformant cells were selected with 10 g.ml−1
zeocin, 50 g.ml−1 hygromycin and 10 g.ml−1 neomycin.
For RNAi analysis, each cell line was diluted into two
different cultures of 5.5 × 105 cells. ml−1. To one of these,
2 g.ml−1 tetracyclin (Calbiochem R©, Merck Millipore)
was added (Tet + sample) to induce the gene-specific
RNAi, while the other culture was used as the non-induced
(Tet-) sample. The cell density in both cultures was then
assessed post-tetracycline addition using a Neubauer
improved hemocytometer. At 6, 12 and then every 24 h,
∼107 cells were collected for EdU incorporation and cell
cycle (DAPI staining of nuclear and kinetoplastid DNA)
analysis (described in specific sections). In parallel, ∼107
cells were collected for cell cycle analysis by flow cytometry.
Briefly, cells were centrifuged at 1620 g for 10 min, washed
once in 1x PBS supplemented with 5 mM EDTA, and
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re-suspended in 300 l of 1x PBS supplemented with 5
mM EDTA, to which 700 l of Methanol (cooled at 4◦C)
was added in a drop-wise fashion while vortexing (final
fixing solution of 70% (v/v) Methanol), and left at least
overnight at 4◦C. The cells were then centrifuged at 1620
g for 10 min at 4◦C, washed once in 1x PBS supplemented
with 5 mM EDTA, and finally re-suspended in 1 ml of
1x PBS supplemented with 5 mM EDTA, 10 g.ml−1
propidium iodide (PI; Sigma-Aldrich), and 10 g.ml−1
RNaseA (Sigma-Aldrich), and incubated for 45 min at
37◦C, protected from light. The cells were then passed
through a 35 m nylon mesh cell strainer (BD Biosciences)
and analysed using a BD FACSCaliburTM system (BD
Biosciences). Data was acquired from the FSC, SSC, FL2-
W and FL2-A detectors using BD CellQuestTM software
(BD Biosciences), and further analysed and graphically
represented using the C©FlowJo software, version 10. To
assess mRNA knockdown efficiency, the levels of mRNA
were analysed by quantitative real-time PCR (RT-qPCR).
Briefly, ∼2 × 107 cells were collected and total RNA ex-
tracted using the RNeasy Mini Kit (Qiagen), according to
the manufacturer instructions. Next, 1 g of total mRNA
was converted into cDNA using the SuperScriptTM III
Reverse Transcriptase Kit (Life Technologies), according
to the manufacturer. For the RT-qPCR reaction, primers
were designed using the Primer Express version 3.0 soft-
ware (Bio Rad), and according to established guidelines
(61,62): TbORC4––AGGCAGTGAAGTCATTGTGG
and AAGCGCGTAATTCCTGAGAG; TbORC1B––AC
GTCAACTGTGCGGATATG and TCCAAGCGAACC
TGTGAAC; Tb3120––GCTGCTTTGCAGGAAATACC
and GCAGTGAAATGCTTCTGCTG. Primer sequences
targeting TbORC1/CDC6 and the Tb927.10.12970 gene
(here used as the endogenous reference gene for normal-
ization) have been published previously (49,63). For each
pair of primers, triplicates of each sample cDNA (diluted
1:10) were run per plate (MicroAmp R© Optical 96-well
Reaction Plate, Applied Biosystems R©, Life Technologies),
using PrecisionTM qPCR MasterMix with SYBR Green
and low ROX (Primerdesign), as recommended by the
manufacturer. The qPCR reactions were performed on
a 7500 Real Time PCR system (Applied Biosystems R©),
using the following PCR cycling conditions: 95◦C for 10
min, followed by 40 cycles of 95◦C for 15 s and 60◦C for 1
min. Fluorescence intensity data was collected at the end
of the extension step (60◦C for 1 min), and analysed by
relative quantification using the Ct method (64), and
the non-induced sample (Tet-) as the calibrator, on the
7500 software version 2.3 (Applied Biosystems R©).
RNA interference analysis in BSF cells
RNAi analysis in BSF cells was performed using a strategy
described previously (65). Here, each gene fragment was
PCR-amplified using a pair of primers containing the
attB1 (forward primer) and attB2 sites, and cloned into
the pGL2084 plasmid vector, in a site-specific BP recom-
bination reaction, using the Gateway R© BP clonase R©
II Enzyme mix Kit (Life Technologies), as described
by the manufacturer. The following primers were used:
TbORC1/CDC6––GGGGACAAGTTTGTACAAAA
AAGCAGGCTGAAGCCCACAGCTGTCTTTC and
GGGGACCACTTTGTACAAGAAAGCTGGGTTTC
TCCGGCAACTTGTAACC; GGGGACCACTTTGTAC
AAGAAAGCTGGGTTTCAGTTTCGCCGAAGTTCT;
TbORC1B––GGGGACCACTTTGTACAAGAAA
GCTGGGTTTTGCGATTTGACTGTCTCG and
GGGGACAAGTTTGTACAAAAAAGCAGGCTC
TATCGGCTGAGTACGCCTC. The resulting constructs
were then digested with AscI, transfected into BSF Lister
427 cells, strain 2T1, with TbORC1/CDC6 or TbORC1B
endogenously tagged with 12myc at the C-terminus (as
described in a previous section). Transformant cells were
selected with 5 g.ml−1 hygromycin, in the presence of 2.5
g.ml−1 phleomycin and 10 g.ml−1 blasticidin, and tested
for susceptibility to puromycin (0.2 g.ml−1). For RNAi
analysis, each cell line was diluted into two different cultures
of 1 × 104 cells. ml−1, in HMI-11 thymidine-free media.
To one of these, 1 g.ml−1 tetracyclin (Calbiochem R©,
Merck Millipore) was added (Tet + sample) to induce the
gene-specific RNAi, while the other culture was used as
the non-induced (Tet-) sample. The cell density in both
cultures was then assessed using a Neubauer improved
hemocytometer. At each time point, 3 ml of each culture
was collected for EdU incorporation and cell cycle (DAPI
staining of nuclear and kinetoplastid DNA) analysis (de-
scribed in specific sections). RNAi efficiency was assessed
by western blot (below).
EdU incorporation and quantification in PCF and BSF cells
Exponentially growing PCF cells were incubated with 50
M of 5-ethynyl-2′-deoxyuridine (EdU; Life Technologies)
for 3 h at 27◦C, while BSF cells were incubated with 150
M of EdU for 4 h at 37◦C and 5% CO2. The cells were
then collected and centrifuged at 1620 g (PCF) or 1000 g
(BSF) for 10 min, washed once in 1x PBS (pH 7.2), and
the pellet re-suspended in 200 l of 1x PBS. Next, 20 l
of the cell suspension was loaded onto each well of a 12
multi-well glass slide (Thermo Scientific) previously treated
with Poly-L-lysine (Sigma-Aldrich), and allowed to settle
for 4 min. The cells were then fixed for 15 min (PCF) or
5 min (BSF) with 3.7% paraformaldehyde (Sigma-Aldrich)
in 1x PBS. The cells were washed three times, 5 min each,
with 3% BSA (Sigma-Aldrich) in 1x PBS, and permeabi-
lized for 20 min (PCF) or 10 min (BSF) with 0.2% Triton
X-100 (Promega), diluted in 1x PBS. The cells were then
washed twice with 3% BSA, and incubated with 25 l of
the Click-iT R© EdU detection mix (Life Technologies) for 1
h, protected from light. The Click-iT R© EdU detection mix
was composed of 21.5 l of 1x Reaction Buffer, 1 l of cop-
per sulphate (CuSO4), 0.06 l (PCF cells) or 0.25 l (BSF
cells) of Alexa Fluor R© 555, and 2.5l of 1x Reaction Addi-
tive. The cells were then washed 4–6 times with 3% BSA, af-
ter which Fluoromount G containing DAPI mounting me-
dia (Cambridge Bioscience, Southern Biotech) was added,
the slide covered with a coverslip, and sealed with regular
nail varnish. In the case of imaging both incorporated EdU
and 12myc-tagged proteins, the cells were incubated for 1
h, protected from light, with 20 l of mouse anti-myc clone
4A6AlexaFluor R© 488 conjugate antiserum (Millipore), di-
luted 1:500 in 1% BSA in 1x PBS, and washed three times
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with 3% BSA, before adding the mounting media. Images
were acquired using a Zeiss Axioskop 2 fluorescent micro-
scope (63x oil 1.4 NA objective) attached to an HBO100
lamp and a digital ORCA-ER camera and camera con-
troller (Hamamatsu Photonics), using the Volocity R© 6.1.1
Cellular and ImagingAnalysis software (Perkin Elmer). Im-
ages were further analysed using Fiji (66). The numbers
of EdU-positive and EdU-negative cells were assessed us-
ing the Cell Counter plugin, and the percentage of EdU-
positive cells was calculated for each sample (Tet- and Tet+)
per time point. The percentage of EdU-positive cells was
then calculated relative to the percentage of the Tet- sam-
ple (considered to be 100%). Likewise, the number of cells
in the different cell cycle stages was also assessed accord-
ing to the nucleus-kinetoplast ratio, and the percentage of
each cell cycle stage was then calculated to the total sampled
population.
Immunofluorescence of 12myc-tagged proteins in PCF and
BSF cells
Approximately 1 × 107 cells were collected from an expo-
nentially growing PCF cell culture (∼1 × 107 cells.ml−1),
centrifuged for 10 min at 1620 g, and washed once in 1x
PBS. The pellet was then re-suspended in 200 l of 1x PBS,
and 20 l of cell suspension was loaded onto each well of
a 12 multi-well glass slide (Thermo Scientific), previously
coated with Poly-L-lysine (Sigma Aldrich), and allowed to
settle for 4 min. Next, the cells were incubated for 15 min
with 20 l of 3.7% paraformaldehyde in 1x PBS, further
washed three times, for 5 min each, with 20 l of 3% BSA
(Sigma Aldrich) in 1x PBS, and then incubated for 20 min
with 20 l of 0.2% Triton X-100 (Promega), diluted in 1x
PBS. Subsequently, the wells were washed twice with 20
l of 3% BSA in 1x PBS, after which each well was incu-
bated for 1 h, protected from light, with 20 l of mouse
anti-myc clone 4A6Alexa Fluor R© 488 conjugate antiserum
(Millipore), diluted 1:500 in 1% BSA in 1x PBS. Next, each
well was washed three times with 3% BSA in 1x PBS, af-
ter which Fluoromount G containing DAPI mounting me-
dia (Cambridge Bioscience, Southern Biotech) was added,
the slide covered with a coverslip, and sealed with regular
nail varnish. In the case of BSF cells, ∼2 × 106 cells were
collected from an exponentially growing culture (∼1 × 106
cells.ml−1), and centrifuged for 5 min at 1000 g. The cells
were then washed in 1x PBS, and re-suspended in 50 l of
1x PBS, to which 250 l of 3.7% paraformaldehyde (Sigma-
Aldrich) were then added, and incubated for 5 min. Next,
10 ml of 1x PBS was added, and the cells centrifuged for
5 min at 1000 g. The cells were then re-suspended in 20
l of 1x PBS, and loaded onto each well of a 12 multi-
well glass slide (Thermo Scientific), previously coated with
Poly-L-lysine (Sigma Aldrich), and let to settle for 5 min.
The cells were permeabilized with 20 l of 0.2% Triton X-
100 (Promega) for 10 min, after which the cells were treated
as described above for PCF cells. For the quantification of
the signal intensity of each 12myc-tagged protein through-
out the cell cycle, images were acquired with a Zeiss Ax-
ioskop 2 fluorescent microscope (63x oil 1.4 NA objective)
attached to anHBO100 lamp and a digital ORCA-ER cam-
era and camera controller (Hamamatsu Photonics), using
the Volocity R© 6.1.1 Cellular and Imaging Analysis soft-
ware (Perkin Elmer), and further analysed with Fiji (66).
The number of cells containing myc signal was assessed us-
ing the Cell Counter plugin. In the case of measuring the
intensity of the detected fluorescent signal (DAPI andmyc),
each image was treated using the Rolling Ball background
subtraction plugin, set up with a radius of 50 pixels, and a
circular 21 × 21 pixel region of interest (ROI) was drawn
around each individual cell nucleus, and the mean pixel in-
tensity within the ROI was measured. Images of both PCF
and BSF cells were also obtained using a 100x oil immer-
sion 1.4 NA objective on an DeltaVision Core microscope
(Image Solutions, UK), equipped with a CoolSNAP HQ2
CCD camera (Photometrics R©). Z-stacks of 5 m thick (25
sections, 0.2 m thickness each) were acquired with a 512×
512 resolution using the SoftWoRx suite 2.0 software (Im-
age Solutions, UK), and deconvolved using the ratio con-
servative method applied by the SoftWoRx software. These
were further analysed with Fiji (66).
Super-resolution imaging and analysis
Super-resolution Structured illumination (SR-SIM) mi-
croscopy was performed using an Elyra PS.1 super-
resolution microscope equipped with a sCMOS PCO cam-
era (Zeiss, Germany). The Plan-Apochromat 100x oil 1.46
NA objective was used, and Z-stacks of 4 m thick (45
sections of 0.09 m thickness each) were acquired using
the ZENBlack Edition Imaging software (Zeiss, Germany).
Five-phase SR-SIM images were reconstructed in the same
software using the Structural Illumination manual process-
ing tool. Maximum projection SR-SIM images were pro-
cessed in their final form using FIJI (66) and Adobe Photo-
shop.
Gel filtration
AHiLoad 16/60 Superdex 200 Prep Grade (GEHealthcare
Life Sciences) column, set up in a A¨KTApurifier system
(GE Healthcare Life Sciences), and controlled with Uni-
corn 5.31 software (GEHealthcare Life Sciences), was used.
Prior to sample injection, the column was equilibrated with
two column volumes of running buffer (50 mM of HEPES
pH 7.55, 100 mM of NaCl, 1 mM of EDTA pH 8, 1 mM
of EGTA pH 8, 10% Glycerol, 1% Triton X-100, 1 mM of
DTT and 0.25x complete protease inhibitor cocktail), using
a flow rate of 750 l per min. Around 7.5 × 108 cells were
collected from an exponentially growing PCF cell culture
(∼1 × 107 cells.ml−1), centrifuged at 1620 g for 10 min and
washed in 10ml of 1x PBS. The pellet was then re-suspended
in 2 ml of lysis solution (50 mM of HEPES pH 7.55, 100
mM of NaCl, 1 mM of EDTA pH 8, 1 mM of EGTA pH 8,
10%Glycerol, 1% Triton X-100, 1 mMofDTT and 2x com-
plete protease inhibitor cocktail), and incubated on ice for
30 min. Two millilitre of lysate were then transferred into
a 2.2 ml thin wall propylene centrifuge tube (11 × 35 mm)
(Beckman Coulter), and centrifuged at 100 000 g for 1 h,
at 4◦C, using an OptimaTM TL Ultracentrifuge (Beckman
Coulter) equipped with a TLS 55 rotor (Beckman Coulter).
The lysate was then filtered (0.2 m Ministart R© Syringe
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Filter, Sartorius), and injected into the A¨KTApurifier sys-
tem, and run in a total of 210.8 ml of running buffer at a
flow rate of 500 l.min−1. Fractions of 1 ml were collected
into ABgene 2.2 ml 96-well storage plates (Thermo Scien-
tific) for further analysis by western blotting (below).
Fluorescence-activated cell sorting (FACS)
Approximately 1 × 109 cells were collected from an expo-
nentially growing PCF culture (∼1 × 107 cells.ml−1), cen-
trifuged for 10 min at 1620 g and washed in 10 ml of 1x
PBS supplemented with 5 mM of EDTA. The cells were
then re-suspended in 12 ml of 1x PBS supplemented with 5
mM of EDTA, to which 28 ml of 100% ice cold-Methanol
was added, in a drop-wise fashion while vortexing (final fix-
ing solution was of 70% (v/v) methanol and a cell concen-
tration of 2.5 × 107 cells.ml−1). The cells were then kept
at 4◦C from overnight up to three weeks. For every FACS
run, four FACS tubes (Becton Dickinson) were prepared,
each starting with 4 ml of fixed cells (∼1 × 108 cells). The
cells were collected and centrifuged for 10 min at 1620 g, at
4◦C, washed in 1 ml of 1x PBS supplemented with 5 mM of
EDTA, re-suspended in 4 ml of 1x PBS supplemented with
5 mM of EDTA, 10 g.ml−1 of PI (Sigma Aldrich) and 10
g.ml−1 of RNase A (Sigma Aldrich), and incubated for 45
min at 37◦C, protected from light. The cells were then trans-
ferred to a FACS tube through a cell strainer cap (BD Bio-
sciences), and sorted into G1, early S, late S and G2 phases
using a BD FACSAria ITM Cell Sorter (BD Biosciences).
The sorted cells were collected at 4◦C into new FACS tubes
containing 200 l of 1x PBS supplemented with 5 mM of
EDTA. The collected cells were then centrifuged at 2000 g
for 10 min, and re-suspended in 10 l of 1x NuPAGE R©
LDS Sample Buffer (Life Technologies), and used for west-
ern blot analysis.
Western blot
Approximately 2.5 × 106 PCF or BSF cells were collected
for immunodetection of the proteins of interest by west-
ern blot. The 12myc-tagged proteins were detected using
the mouse anti-myc clone 4A6 antiserum (diluted 1:7000;
Millipore), while 6HA-tagged proteins were detected us-
ing the mouse anti-HA clone HA-7 antiserum (diluted 1:10
000; Sigma-Aldrich).Whenever necessary, the transcription
elongation factor Ef1 was used as a loading control and
detected with the mouse anti-Ef1 clone CBP-KK1 an-
tiserum (diluted 1:25 000; Millipore). The three antisera
were used in combination with the goat anti-mouse IgG
(H+L) horseradish peroxidase conjugate (diluted 1:5000;
Life Technologies).
Statistical analysis
All statistical analyses were performed using Prism 6
(GraphPad software Inc.), and the statistical tests used are
described in the figure legend of the corresponding graph.
Protein sequence analysis and structure prediction
Gene and protein sequences (TbORC1/CDC6 –
Tb927.11.7216; TbORC1B – Tb927.9.2030; TbORC4
– Tb927.10.13380; Tb3120 – Tb927.9.4530; and Tb7980
– Tb927.10.7980) were retrieved from the TriTrypDB
online database (http://tritrypdb.org/tritrypdb/). For pro-
tein homology searches, protein sequences were analysed
using the standard (default settings) protein–protein
Basic Local Alignment Search Tool (BLAST) (blastp)
(http://blast.ncbi.nlm.nih. gov/Blast.cgi), with the non-
redundant protein sequences database (nr). For protein
structure and function prediction, the RaptorX (67) online
server was used. Protein alignments were performed using
CLC genomics Workbench, with a gap open cost of 10.0,
gap extension cost of 1.0, end gap cost of ‘as any other’,
and the very accurate (slow) option for alignment. Protein
domain searches were performed using Pfam, version 27.0
(http://pfam.xfam.org/), using default settings. Figures rep-
resenting the predicted structure of Tb3120 and Tb7980,
as well as the structures of D. melanogaster Orc2 and Orc5
(imported from RCSB Protein Bank Database) subunits,
were generated in CLC genomics Workbench.
RESULTS
TbORC4 and Tb3120, two TbORC1/CDC6-interacting fac-
tors, contribute to nuclear DNA replication
To facilitate gene function analysis, both PCF and BSF life
cycle stages ofT. brucei have been genetically modified to al-
low tetracycline (Tet) inducible expression of gene-specific
dsRNA, allowing controlled activation of RNAi against
any gene. Two different strategies to express gene-specific
dsRNA from the rRNA locus have been adopted: insertion
of a target gene fragment between opposing Tet-controlled
promoters (68,69) and insertion of inverted repeats of a gene
fragment to generate stem-loop RNA from a single Tet-
controlled promoter (70–72). Previously, we reportedRNAi
against TbORC1/CDC6, TbORC4, Tb7980 and Tb3120 in
PCF cells by the former approach, which resulted in re-
markably mild growth and cell cycle defects, visible only>4
days post RNAi induction (49). Perhaps due to the weak-
ness of these RNAi effects, testing if loss of these factors
caused impaired nuclear DNA replication was inconclu-
sive (49). Because RNAi mediated by stem-loop RNAs has
been suggested to be more efficient, we sought to generate
PCFRNAi cell lines for each of putativeT. bruceiORC-like
factors using stem-loop constructs. Figure 1 shows the ef-
fect of induced stem-loop RNAi against TbORC1/CDC6,
TbORC4 and Tb3120. Unfortunately, we were unable to
generate a stem-loop RNAi cell line targeting Tb7980, for
reasons that remain unclear.
Tet-induced RNAi against TbORC1/CDC6 or TbORC4
resulted in strikingly similar phenotypes. For both factors,
a growth defect (Figure 1A) was seen from 48 h after RNAi
induction, with growth slowing until∼96 h and subsequent
cell death. Concomitant with growth impairment, aberrant
cells were detected by DAPI staining (Figure 1B). In T. bru-
cei the nuclear (N) and kinetoplastid (K) genomes possess
distinct S phase timing, with replication and segregation
of the latter being complete before the former (73). There-
fore, analysis of the ratio and morphology of the nucleus
and kinetoplast delineates the cell cycle stage of individual
cells in an asynchronous population: most 1N1K cells are
in G1 phase; 1N1eK (elongated––replicating––but not yet
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Figure 1. Effect of induced RNAi against TbORC1/CDC6, TbORC4 or Tb3120 in PCF T. brucei. (A) Growth curves of uninduced (Tet-) and tetracycline-
RNAi induced (Tet+) cell cultures over 5 (TbORC1/CDC6 and TbORC4) or 7 days (Tb3120). Cell concentration was assessed every 24 h and the mean
concentration from two independent experiments is shown; error bars depict the standard error of the mean (SEM). Red arrows denote times at which
a 1:10 dilution of the Tet- or Tet+ cultures was carried out at selected time points after RNAi induction. Insert box: efficiency of RNAi knockdown of
mRNA levels assessed by RT-qPCR at selected time points after RNAi induction. The results represent the levels of mRNA in the Tet+ sample relative
to non-induced, calculated using the Ct method. The mean of two independent experiments is shown, and error bars represent SEM. For TbORC4,
the levels of the endogenously 12myc-tagged TbORC4 were assessed by western blot analysis of whole cell extracts 24 and 48 h after RNAi induction (+)
or without induction (-); T.brucei Elongation factor 1  (Ef1) was used as a loading control. (B) Quantification of the proportion of different cell types
throughout the course of the RNAi induction, based on the number of nuclei (N) and kinetoplasts (K) detected in individual cells stained with DAPI. A
minimum of 150 cells were counted per time point and experimental group (Tet- and Tet+), and percentages of each cell type (1N1K, 1N2K, 2N2K, 0N1K
and others) were calculated relative to the total amount of cells analysed. The graph represents the mean of each cell type observed in two independent
experiments, while the error bars show SEM. (C) Percentage of cells displaying nuclear EdU signal in the Tet+ samples relative to the number of EdU
positive cells in the Tet- culture from the same time point. A minimum of 150 cells were analysed per time point and group (Tet- and Tet+) and the mean
from two independent experiments is shown; error bars represent the SEM. The insert in the Tb3120 column shows an example of an EdU positive cell,
relative to the same cell DAPI-stained and DIC imaged; scale bar represents 5 m.
divided kinetoplast) are in S phase; 1N2K cells are in S-G2
phase and 2N2K cells are post-mitotic (74). A dramatic in-
crease in numbers of enucleated cells (0N1K or zoids) (75)
was seen after RNAi for both genes: zoids represented only
∼1–3% of the populations prior to RNAi induction, but in-
creased to 50–60% 48 h post-induction and reached a max-
imum of ∼70% at ∼72 h (Figure 1B). Concurrently, the
numbers of 1N1K cells decreased from ∼80% of the unin-
duced populations to ∼15% from 72 h onwards, and 2N2K
cells were virtually abolished from both populations by 72
h post-induction. Though increased levels of 1N2K cells
might be expected if replication was affected and a G2/M
checkpoint was enacted, there was little evidence for this;
indeed, if anything, levels of 1N2K cells decreased. At late
time points some further abnormal cells could be seen be-
yond the predominant zoids; we have referred to these cells
as ‘others’ because no predominant N-K ratio could be dis-
cerned and they frequently displayed an irregular cellular
shape (Supplementary Figure S1). The cell cycle effects fol-
lowing RNAi were supported by flow cytometry analysis of
PI-stained cells (Supplementary Figure S2): from 48 h on-
wards, an increase in a sub-G1 population (<2n DNA con-
tent, suggesting lack of a nucleus) was observed, in parallel
with a decrease in G1 (2n) andG2/M(4n) cells, which by 96
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h after RNAi induction was profound. The levels of 0N1K
cell accumulation presented here exceed that described in
previous RNAi studies on these factors (49,53), as does the
timing of onset and severity of the growth defects, perhaps
suggesting that the RNAi approach was more effective, de-
spite the fact that quantitative RT-qPCR suggested only
a ∼60% reduction in TbORC1/CDC6 mRNA 24 h after
RNAi induction (Figure 1A). Indeed, since RT-qPCR sug-
gested a very modest loss of TbORC4 mRNA at the same
time point (∼20%), TbORC4 was endogenously tagged at
theC-terminuswith 12 copies of themyc epitope (see below)
in the RNAi cell line targeting TbORC4, revealing that the
protein was undetectable 48 h after RNAi induction (Figure
1A).
RNAi against Tb3120 resulted in a later and milder
growth defect than seen for TbORC1/CDC6 or TbORC4,
only apparent ∼96 h after induction (Figure 1A). Nonethe-
less, like for TbORC1/CDC6 and TbORC4, the growth de-
fects following Tb3120RNAi correlatedwith the accumula-
tion of aberrant cells (initially zoids and, later, ‘others’) and
increasing loss of 1N1K and 2N2K cells in the population
(Figure 1B), suggesting a comparable RNAi response. Flow
cytometry analysis confirmed these observations, as sub-
G1 cell accumulation was detected from 96 h after RNAi
induction, and G1 and G2 cells were strongly reduced by
168 h (Supplementary Figure S2). Why the RNAi pheno-
types accumulated more slowly upon Tb3120 depletion is
unclear, since RT-qPCR suggested similar levels of Tb3120
mRNA loss (∼50% at 24, 48 and 96 h) to those seen for
TbORC1/CDC6 (Figure 1A).
Recently, loss of TbORC1/CDC6 has been shown to
impair DNA replication, since a decrease in the levels
of bromo-5′-deoxyuridine (BrdU) incorporation was de-
tected after RNAi induction (54). To corroborate these ob-
servations, and to extend them to the TbORC1/CDC6-
interacting factors, we evaluated uptake of 5-ethynyl-2′-
deoxyuridine (EdU;which is also an analogue of thymidine)
(76) after TbORC1/CDC6, TbORC4 or Tb3120 RNAi
(Figure 1C). For this assay, both non-induced and induced
cells were incubated with EdU for 3 h and uptake examined
by fluorescent microscopy (Figure 1C, insert box). The per-
centage of EdU-labelled cells in the RNAi-induced sample
was calculated relative to the number of EdU-positive cells
in the non-induced sample (Figure 1C). For all three factors,
the number of EdU-positive cells decreased with time in the
RNAi induced cells relative to the uninduced, and the ex-
tent of the loss mirrored the severity of the growth and cell
cycle phenotypes, with earlier loss after TbORC1/CDC6 or
TbORC4 RNAi (both reduced by ∼50% at 24 h) than for
Tb3120 (∼60% reduction at 72 h) (Figure 1C). Importantly,
in all cases the timing of EdU incorporation decrease pre-
ceded the appearance of growth or cell cycle defects, arguing
that the aberrant cells are a consequence, not the cause, of
impaired nuclear DNA replication.
TbORC1B acts in T. brucei nuclear DNA replication
TbORC1B RNAi silencing, which has not to date been
reported, resulted in the most severe growth defect of all
the factors tested, evident as early as 24 h post-induction
(one day before any growth effect was observed following
TbORC1/CDC6 or TbORC4 RNAi; Figure 2A). Due to
this rapid response, cell cycle and EdU incorporation anal-
yses were conducted at earlier time points. Six hours after
RNAi induction, when RT-qPCR showed ∼40–50% loss of
TbORC1BmRNA (Figure 2A), there was no increase in the
proportion of zoids or other aberrant cells (below), but a
small increase in 1N2K and 2N2K cells was observed, to-
gether with a decrease in 1N1K cells (Figure 2B). Twelve
hours after RNAi induction, a small increase in zoids was
noticeable, together with a pronounced increase in 1N2K
cells and decrease in both 1N1K and 2N2K cells, suggest-
ing an accumulation of cells in G2/M phase and a decrease
in G1 phase cells. However, this was not supported by flow
cytometry analysis, where an increase in the G1 (2n) pop-
ulation and a decrease in the G2/M (4n) population was
observed instead (Figure 2D). Quantification of EdU la-
belling revealed ∼60 and ∼90% reduction in EdU positive
cells by 6 and 12 h post-induction (Figure 2C), respectively,
indicating that cells morphologically classified as 1N2K at
these time points have not replicated their nuclear DNA,
although the kinetoplast has replicated and segregated as
normal. As for the other factors, reduced EdU incorpora-
tion preceded the emergence of aberrant cells: at 24 h post-
induction, when EdU incorporation was essentially unde-
tectable (Figure 2C), >55% of the population was com-
posed of zoid cells (Figure 2B), while both 1N1K and 1N2K
populations were reduced, and virtually no 2N2K cells were
observed, mirroring the cell cycle phenotypes seen at ∼48 h
post RNAi for TbORC1/CDC6 or TbORC4. These cell cy-
cle defects were reflected in the flow cytometry analysis at
24–48 h post RNAi, which showed a pronounced reduction
in both G1 (2n) and G2/M (4n) cell populations, and an in-
crease in the levels of sub-G1 cells (Figure 2D). Between 48
and 72 h post-induction cell growth stalled (Figure 2A) and
thereafter cell numbers decreased, which was accompanied
by an increase in the number of zoids to ∼70–80% of the
population (Figure 2B), in parallel with a further decrease
in 1N1K and 1N2K cells, complete loss of 2N2K cells and a
small increase in ‘others’ (reaching ∼15% at the latest time
point, 120 h).
TbORC1B differs from all other identified TbORC1/CDC6
interacting factors in displaying cell cycle regulated expres-
sion
Both T. brucei and T. cruzi ORC1/CDC6 proteins have
been reported to localize to the nucleus and associate
with chromatin throughout the cell cycle of replicat-
ing cells (53,77). To compare this localization pattern
with the TbORC1/CDC6 interacting factors, each pro-
tein was tagged at its endogenous locus with 12 copies
of the c-myc epitope (12myc), either at the C-terminus
(TbORC4, TbORC1B andTb3120), as described previously
for TbORC1/CDC6 (49), or at the N-terminus (Tb7980),
using amodified version (gift, A. Trenaman) of the pEnT6B
construct (59). Expression of the tagged proteins in PCF
cells was confirmed by western blot (Supplementary Fig-
ure S3A), and no cell growth (Supplementary Figure S3B),
cell cycle (Supplementary Figure S3C) or EdUuptake (Sup-
plementary Figure S3D) defects were detected in these
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Figure 2. Effect of induced RNAi against TbORC1B in PCF T. brucei. (A) Growth curves of uninduced (Tet-) and tetracycline-RNAi induced (Tet+)
cell cultures over five days, where cell concentration was assessed every 24 h; mean concentration from two independent experiments is shown and error
bars depict the standard error of the mean (SEM). Insert box: efficiency of RNAi knockdown of TbORC1B mRNA levels assessed by RT-qPCR. The
results represent the amount of mRNA at the time points shown after RNAi induction (Tet+) relative to the non-induced sample (Tet-). The mean of two
independent experiments is shown, and the error bars represent SEM. (B) Quantification of the proportion of different cell cycle types throughout the
course of the RNAi induction, based on the number of nuclei (N) and kinetoplasts (K) detected in individual cells stained with DAPI. A minimum of 150
cells were counted per time point and experimental group (Tet- and Tet+), and percentages of each cell type (1N1K, 1N2K, 2N2K, 0N1K and others)
were calculated relative to the total amount of cells analysed. The graph represents the mean of each cell type observed in two independent experiments,
while the error bars show SEM. (C) Percentage of cells displaying nuclear EdU signal in the Tet+ samples relative to the number of EdU positive cells
in the Tet- culture from the same time point. A minimum of 150 cells were analysed per time point and group (Tet- and Tet+) and the mean from two
independent experiments is shown; error bars represent the SEM. (D) Histograms representing the distribution of the cell population according to DNA
content (stained with PI) assessed by flow cytometry at the 6, 12, 24 and 48 h time points. Approximately 30 000 cells were analysed per sample, and the
histograms represent the percentage of cells in the population, normalized to mode; cells with 2n and 4n DNA content are indicated.
cells compared with the parental cell line (927 wt) or the
TbORC1/CDC6–12myc expressing cells (55).
As expected (53), TbORC1/CDC6–12myc localized to
the nucleus of the cell throughout the cell cycle, display-
ing a punctate signal throughout most of the nucleo-
plasm, but apparently excluded from the nucleolus (Figure
3A). Unlike ORC1/CDC6 in T. cruzi epimastigotes (78),
TbORC1/CDC6–12myc did not re-localize to the nuclear
periphery during S phase; instead, TbORC1/CDC6–12myc
distribution was indistinguishable in 1N1K, 1N1eK, 1N2K
or 2N2K cells. Localization of TbORC4–12myc (Figure
3B), Tb3120–12myc (Figure 3C) and 12myc-Tb7980 (Fig-
ure 3D) showed that each of these factors behaves like
TbORC1/CDC6–12myc: all localized, as puncta, to the nu-
cleus of the cell throughout the cell cycle.
TbORC1B-12myc localization was strikingly different
from all the above factors. TbORC1B-12myc was detected
in the nucleus of only ∼33% of cells (Figure 4A and B),
in contrast to TbORC1/CDC6–12myc, TbORC4–12myc,
Tb3120–12myc and 12myc-Tb7980, where signal was de-
tected in 100% of the cells (Figure 4A). Categorization of
theN-K ratio of the cells showed that TbORC1B-12myc sig-
nal was not evenly distributed amongst the identifiable cell
cycle phases (Figure 4B andC): most TbORC1B-12myc sig-
nal (∼72.5%) was found in 1N1eK cells, while the remain-
der was observed in both 1N1K and 1N2K cells (∼16.8 and
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Figure 3. Immunofluorescence localization of TbORC1/CDC6, TbORC4, Tb3120 and Tb7980 in PCF T. brucei cells. Analysis of the subcellular local-
ization of 12myc tagged variants of TbORC1/CDC6 (A), TbORC4 (B), Tb3120 (C) and Tb7980 (D) are shown in fixed cells. In each case the cells are
shown stained with DAPI, allowing their classification as 1N1K cells (G1 phase), 1N1eK cells (S phase), 1N2K cells (G2/M phase) and 2N2K cells (post-
mitosis). The tagged proteins are detected in each cell type using an anti-myc antiserum coupled with the Alexa Fluor 488 flurophore (myc, green). Finally,
the outline of all cells is shown by DIC imaging. Arrows direct the reader’s attention to single cells of the expected cell cycle stage if more than one cell is
shown. Images were acquired using a DeltaVision imaging system and deconvolved using the ratio conservative method, on SoftWoRx software. The scale
bar represents 5 m.
∼10.7%, respectively). Quantifying each cell cycle phase
(Figure 4D) showed that ∼10.4% of 1N1K cells, ∼72%
of 1N1eK cells and ∼51.6% of 1N2K cells had detectable
TbORC1B-12myc signal, while no signal was observed in
cells undergoing mitosis (1N2K cells with elongated nu-
cleus) or in post-mitotic 2N2K cells (Figure 4B). Taken to-
gether, these data suggest that TbORC1B-12myc is only de-
tectable in the nucleus of cells spanning the period from late
G1 (or early S) phase to either late S or G2 phase (Figure
4B). To test this further, TbORC1B-12myc cells in early-
mid G1, early S, late S and G2/M phases were isolated by
fluorescence-activated cell sorting (FACS) and analysed by
western blotting. This revealed that TbORC1B-12myc was
undetectable in G1 phase cells, but was present in the other
sorted cell cycle stages (Figure 4E). Taken together, these
data suggest that TbORC1B protein levels are limited in
non-replicating cells.
Next, we measured the intensity of the DAPI and anti-
myc fluorescence signals in the nuclei of individual myc-
tagged cells, classified into the different cell cycle stages
according to their N–K ratio. For all cell lines (Figure 5;
Supplementary Figure S4), the DAPI fluorescence inten-
sity increased as cells progressed from G1 phase (1N1K)
through S (1N1eK), where cells showed a wider range of
intensity values, most likely representing cells in the differ-
ent points of S phase. The DAPI signal peaked in G2/M
cells (1N2K), with approximately double the G1 signal,
consistent with the DNA being completely replicated (Fig-
ure 5; Supplementary Figure S4). After mitosis (2N2K
cells), the signal of each individual nucleus in the cell re-
turned to intensity values observed in G1 cells. The inten-
sity of TbORC1/CDC6–12myc closely followed the cell cy-
cle dynamics of DAPI (Figure 5A), as did TbORC4–12myc,
Tb3120–12myc and 12myc-Tb7980 (Supplementary Figure
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Figure 4. Cell-cycle dependent nuclear localization of TbORC1B. (A) Percentage of cells containing nuclear myc signal in untagged T. brucei PCF cells
(927 wt) relative to PCF cells expressing TbORC1/CDC6–12myc, TbORC1B-12myc, TbORC4–12myc, 12myc-Tb7980 or Tb3120–12myc, each from the
endogenous locus; the mean of three independent experiments is shown (>125 cells each) and error bars show SEM. (B) Immunofluorescent detection of
TbORC1B-12myc with anti-myc antiserum (middle row) in 1N1K cells (G1 phase), 1N1eK cells (S phase), 1N2K cells (G2/M phase), and 2N2K cells
(post-mitosis), stained with DAPI (top row) and cell outline shown by DIC (lower row). Arrows highlight a single cell of the expected cell cycle stage if
more than one cell is captured in the images. The scale bar represents 5 m. (C) The proportion of cell cycle stages displaying TbORC1B-12myc signal is
shown either as the percentage of total cells (insert box), or as the percentage of positive cells (main graph), as determined by N-K ratio (dark blue, 1N1K
cells; light blue, 1N1eK cells; yellow, 1N2K cells, red, 2N2K). The mean is shown from two independent experiments, and the error bars depict standard
deviation. (D) Percentage of individual cell cycle stage cells that display TbORC1B-12myc signal (as no 2N2K cells were detected to have TbORC1B-12myc
signal, these are not represented); the mean of four independent experiments is represented and error bars show standard deviation. Statistical significance
between the different groups was assessed using the one-way ANOVA parametric test: (***) P-value < 0.001; (****) P-value <0.0001. (E) Asynchronous
TbORC1B-12myc expressing cells were separated into G1, Early S, Late S and G2/Mphases FACS sorting and the western blot shows the sorted fractions
probed with anti-myc antiserum (-myc); the same blot was probed with antiserum against the transcription elongation factor Ef1 as a loading control.
S4). These data suggest the abundance of these factors in the
nucleus increases as the amount of DNA in the nucleus of
the cell increases, peaking when the genome is completely
replicated. Again, the data for TbORC1B-12myc differed
(Figure 5B): for this factor anti-myc signal intensity peaked
in 1N1eK cells, reduced in 1N2K cells and was at back-
ground levels in 2N2K cells. Indeed, the average signal in
1N1K cells was also at background levels, though some cells
showed higher values, consistent with TbORC1B-12myc ex-
pression in only a fraction of this cell type. When taken to-
gether with the western blot data after FACS, it seems likely
that TbORC1B-12myc expression is largely or completely
limited to S-phase cells.
Super-resolution imaging suggests related localization of
TbORC1/CDC6, TbORC4 and TbORC1B
To compare in more detail the pattern of TbORC1/CDC-
12myc, TbORC4–12myc and TbORC1B-12myc localiza-
tion, we examined each using anti-myc immunofluorescence
and super-resolution structure illumination microscopy
(SR-SIM; Figure 6, and see Supplementary Figures S5–S8
for more detail). In addition, we compared the proteins’ lo-
calization with replicating DNA, which was detected with
EdU. The use of SR-SIM allowed us to quantify the sig-
nal intensity and pattern within the nucleus, confirming
that TbORC1/CDC6–12myc and TbORC4–12myc (Figure
6) do not localize homogenously in the nucleus, as the
signals were present in discrete puncta in non-replicating
cells (1N1K, 2N2K). There was no evidence for localiza-
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Figure 5. Quantification of TbORC1/CDC6 and TbORC1B subcellular localization through the cell cycle. Intensity of the DAPI (left graphs, blue dots)
andmyc signals (right graphs, green dots) of PCFT. brucei cells expressing TbORC1/CDC6–12myc (A) or TbORC1B-12myc (B) is represented as the mean
pixel intensity within a circular ROI (21 × 21 pixels), drawn around each individual cell nucleus; for the myc signal data, the red dotted line represents the
average background signal measured in 927 wt cells that do not express any tagged protein. Dark green dots represent cells in which TbORC1B-12myc
signal was not visually detected, while light green dots represent cells with visually detectable TbORC1B-12myc signal. In each case, cells are separated by
cell cycle stage, determined by N-K ratio in the DAPI images: 1N1K cells (G1 phase), 1N1eK cells (S phase), 1N2K cells (G2/M phase) and 2N2K cells
(post-mitosis). The median values derived from the analysis of 591 TbORC1/CDC-12myc cells (1N1K – 1.47; 1N1eK – 2.31; 1N2K – 2.86; 2N2K – 1.48)
and 412 TbORC1B-12myc cells (1N1K – 0.48; 1N1eK – 1.99; 1N2K – 0.71; 2N2K – 0.48) are represented, with error bars depicting the interquartile range.
Statistical significance between the different cell cycle stages was assessed using the Kruskal-Wallis non-parametric test: (*) P-value < 0.05; (**) P-value
< 0.01; (****) P-value < 0.0001.
tion to any specific region within the nucleus. In early S
phase cells (1N1eK) there was limited co-localization be-
tween either TbORC1/CDC6–12myc or TbORC4–12myc
and EdU, which was also seen in puncta. However, over-
lap in the anti-myc and EdU signals became more pro-
nounced in 1N2Kcells, where S phase ismore complete, and
at that cell cycle stage the protein and replication puncta
become more abundant and appeared more diffuse. As
noted previously (79), there was no evidence that EdU sig-
nal accumulated in the periphery of the nucleus, reinforc-
ing the suggestion of a difference in replication dynam-
ics between T. brucei and T. cruzi. In 2N2K cells, after
completion of replication, localization of TbORC1/CDC6–
12myc and TbORC4–12myc returned to a comparable pat-
tern to that of 1N1K cells. The SR-SIM imaging con-
firmed the cell cycle dependence of TbORC1B-12myc nu-
clear localization (Figure 6) and revealed a comparable
pattern to TbORC1/CDC6–12myc and TbORC4–12myc
in replicating cells (1N1eK and 1N2K), with signal again
seen throughout the nucleus in a similarly large number
of puncta and with some overlap with EdU. To ask to
what extent the punctate signals are specific for the three
ORC-related factors, we next performed SR-SIM imag-
ing of PCF cells expressing a C-terminally tagged variant
of the MCM helicase subunit 3 (TbMCM3–12myc) (49).
Though there is evidence that TbMCM3 interacts with pu-
tative TbORC components (see below) (56), at least some
of the MCM2–7 helicase is expected to move with the repli-
some and not therefore be limited to specific genomic sites,
unlike TbORC1/CDC6 (55). Consistent with this sugges-
tion, TbMCM3–12myc signal (Figure 6) was more abun-
dant and more homogenous in the nucleus than any of the
three ORC-related factors, and displayed little obvious vari-
ation in the different cell cycle stages, indicating that each
of TbORC1/CDC6, TbORC4 and TbORC1B displays dis-
tinct sub-nuclear localization to that of TbMCM3.
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Figure 6. Super-resolution imaging of TbORC1/CDC6, TbORC4, TbORC1B and TbMCM3 through the cell cycle. PCF T. brucei cells expressing
TbORC1/CDC6–12myc, TbORC4–12myc, TbORC1B-12myc or TbMCM3–12myc were incubated for 3 h with 150 mEdU, fixed and stained with DAPI
and with AlexaFluor R© 488-conjugated anti-myc antibody, while EdU was detected with AlexaFluor R© 594-conjugated azide. Images were acquired with
a Zeiss Elyra super-resolution microscope system in SIMmode. In each case, representative maximum projection images are shown of cells in the different
cell cycle stages, determined by N-K ratio in the DAPI images: 1N1K cells (G1 phase), 1N1eK cells (S phase), 1N2K cells (G2/M phase) and 2N2K cells
(post-mitosis). All cells are shown as a merge of the EdU (red), anti-myc antiserum (green) and DAPI (blue) signals, whose intensities are quantified in the
plots to the left; signal intensities (y-axes, arbitrary units) were analysed in a horizontal line across the boxed area surrounding the nucleus.
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TbORC1B expression and function are conserved in
mammal-infective T. brucei cells
To ask if the function and cell cycle-dependent expres-
sion of TbORC1B in PCF cells is also seen in mammal-
infective BSF cells, we generated stem-loop RNAi con-
structs (65) for the individual targeting of TbORC1/CDC6
or TbORC1B. The constructs were introduced into BSF
2T1-derived (80) cells expressing either TbORC1/CDC6
or TbORC1B endogenously tagged with 12myc. Twenty-
four hours after RNAi induction, when TbORC1/CDC6–
12myc or TbORC1B-12myc was no longer detectable by
western blotting (Figure 7A, insert box), individual loss of
the proteins resulted in cell death (Figure 7A). The greater
rapidity and severity of growth impairment in BSF cells
after TbORC1/CDC6 RNAi when compared with PCF
cells is consistent with previous observations (49), despite
the different RNAi strategy used here. Growth impair-
ment was accompanied by a reduction in 1N1K, 1N2K
and 2N2K cells and the accumulation of aberrant cells
(Figure 7B), which were common to TbORC1/CDC6 and
TbORC1B RNAi, but differed from those seen after PCF
RNAi: 0N1K cells were detected, but were rare, and in-
stead enlarged BSF cells with multiple nuclei and/or kine-
toplasts predominated (examples in Figure 7D), consistent
with previous reports of TbORC1/CDC6 RNAi in BSF
cells (49). In common with the RNAi assays in PCF cells,
aberrant cells arose more quickly and accumulated to a
greater extent after TbORC1B RNAi-induction compared
with TbORC1/CDC6, and this effect correlated with an
earlier onset of loss of EdU incorporation (Figure 7C).
Taken together, these data indicate that, like in PCF cells,
the loss of either TbORC1/CDC6orTbORC1B impairs nu-
clear DNA replication in BSF T. brucei.
To ask if the localization of TbORC1/CDC6 and
TbORC1B, as well as the other TbORC1/CDC6-
interacting factors, is conserved between PCF and BSF
life cycle stages, all genes were 12myc-tagged in Lister 427
BSF cells and expression of the epitope tagged proteins
confirmed (Supplementary Figure S10A). Immunofluo-
rescence microscopy showed that TbORC1/CDC6–12myc
(Supplementary Figure S9A) was, like TbORC4–12myc,
Tb3120–12myc and 12myc-Tb7980 (Supplementary Fig-
ure S9B, C and E), detectable in the nucleus of all BSF
cell cycle stages. In contrast, TbORC1B-12myc showed
essentially the same cell cycle-dependent localization in
BSF cells (Supplementary Figures S9D and S10B–D) as
described in PCF cells, with nuclear signal being most
pronounced in 1N1eK and 1N2k cells (∼90 and ∼50%,
respectively), more limited in 1N1K cells (∼20%) and
virtually undetectable in 2N2K cells (only one cell in >200
examined) (Supplementary Figure S10D). It seems likely,
therefore, that TbORC1B expression is limited to S phase
in all replicating T. brucei cell types.
TbORC1/CDC6, TbORC4 and TbMCM3 are present in a
common high molecular weight complex in T. brucei
Though each of TbORC4, Tb3120, Tb7980 and TbORC1B
has been reported to interact with TbORC1/CDC6 (49,56),
it remains unclear if these proteins interact together in
a complex or individually with TbORC1/CDC6. To ad-
dress this, gel filtration analysis was conducted. First, ex-
tracts from PCF TbORC1/CDC6–12myc expressing cells
were subjected to size exclusion chromatography and the
presence of TbORC1/CDC6–12myc in a wide range of
collected fractions (from immediately after the void to
the fraction potentially containing the monomeric form
of TbORC1/CDC6) was analysed by western blot (Fig-
ure 8A). No signal was detected in fractions correspond-
ing to monomeric TbORC1/CDC6–12myc (∼66 kDa),
and instead TbORC1/CDC6–12myc was detected in frac-
tions corresponding to proteins ranging from ∼1334 to
530 kDa, suggesting inclusion in a protein complex (Fig-
ure 8A). To examine the composition of the complex
further, gel fitration was performed using PCF cells co-
expressing TbORC1/CDC6–12myc and TbORC4–6HA,
or TbORC1-CDC6–12myc and MCM3–6HA (Figure 8B).
TbMCM3 has been previously described to interact with
both TbORC1/CDC6 and TbORC1B (56), and its ortho-
logue in S. cerevisiae, MCM3, has been shown to be the
helicase subunit that mediates recruitment of MCM2–7 to
DNA-bound ORC (81). Western blotting with both anti-
myc and anti-HA antisera showed overlap of the frac-
tions containing TbORC1/CDC6–12myc and both of the
HA-tagged factors, corresponding to proteins ranging from
∼1011 to 530 kDa (Figure 8B). Unlike TbORC1/CDC6–
12myc, both TbORC4–6HA and TbMCM3–6HA could
be found in fractions corresponding to smaller proteins,
though in neither case did these fractions match the ex-
pected size of the monomers (∼84 and ∼96 kDa, respec-
tively). Whether these signals arise from some instability
in association of TbORC4 and TbMCM3 with the larger
complex or might represent inclusion of these factors in
a subcomplex is unclear. Nonetheless, the overlapping sig-
nals of the three factors indicate that TbORC1/CDC6 and
TbORC4 can interact in a large complex, which may addi-
tionally contain at least one subunit of the MCM2–7 heli-
case.
DISCUSSION
This work has examined the machinery that acts in the
initiation of nuclear DNA replication in T. brucei. Previ-
ously, only one factor, TbORC1/CDC6, had been shown
to be involved in DNA replication, both through its
localization to origins (55) and the demonstration that
TbORC1/CDC6-targeting RNAi reduces the number of
replicating cells in the population (54). Here we show that at
least three TbORC1/CDC6-interacting factors, TbORC4,
Tb3120 and TbORC1B (49,56), contribute to DNA repli-
cation, since RNAi of each of these factors impairs nuclear
DNA replication and leads to similar growth and cell cycle
defects. To date, interaction of TbORC1/CDC6 and these
factors in an ORC-like complex has not been tested. We
now provide evidence that TbORC1/CDC6 is stably asso-
ciated with a high molecular weight complex, which also
contains TbORC4 and perhaps TbMCM3. Taken together,
these data are consistent with the initiation of DNA repli-
cation in T. brucei not being mediated by TbORC1/CDC6
alone, as previously suggested (53), but by a diverged ORC-
like complex, which may be part of a pre-RC. Many of the
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Figure 7. Effect of induced RNAi against TbORC1/CDC6 or TbORC1B in bloodstream form T. brucei. (A) Growth curves of uninduced (Tet-) and
tetracycline-RNAi induced (Tet+) cells targeting TbORC1/CDC6 (left) or TbORC1B (right) are shown over 3 days. Cell concentration was assessed every
24 h and the mean concentration from two independent experiments is shown; error bars depict the SEM. Levels of 12myc-tagged protein are shown at
24 h time with (+) or without (-) RNAi induction by western blotting of whole cell extracts with anti-myc antiserum (-myc); loading controls are shown
by probing the same blot with antiserum against T.brucei Ef1; size markers are indicated. (B) Quantification of the proportion of different cell types
throughout the course of the RNAi induction, based on the number of nuclei (N) and kinetoplasts (K) detected in individual cells stained with DAPI. A
minimum of 125 cells were counted per time point and experimental group (Tet- and Tet+), and percentages of each cell type (1N1K, 1N2K, 2N2K, 0N1K
and others) were calculated relative to the total amount of cells analysed. The graph represents the mean of each cell type observed in two independent
experiments, while the error bars show SEM. (C) Percentage of cells displaying nuclear EdU signal in the Tet+ samples relative to the number of EdU
positive cells in the Tet- culture from the same time point. A minimum of 125 cells were analysed per time point and group (Tet- and Tet+) and the mean
from two independent experiments is shown; error bars represent the SEM. (D) Examples of aberrant cells after TbORC1/CDC6 RNAi, stained with
DAPI, and cell outline shown as a DIC image.
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Figure 8. Gel filtration of T. brucei cell extracts. (A) Detection of TbORC1/CDC6–12myc with the myc antiserum in the different fractions resulting from
gel filtration of TbORC1/CDC6 -/12myc cell line lysates. Multiple membranes spanning the fractions are aligned, and the estimated molecular weight is
shown next to the corresponding fraction by a black arrow. The eluted volume (ml) corresponding to each fraction is depicted below each membrane. (*)
pinpoints the lanes loaded with the lysed sample prior gel filtration, as a positive control in each western blot membrane. Size markers (kDa) are indicated.
(B) Gell filtration of cell extracts from T. brucei PCF cells expressing either TbORC1/CDC6–12myc and TbORC4–6HA, or TbORC1/CDC6–12myc and
TbMCM3–6HA. Extracts from the two cell lines were combined prior to gel filtration and proteins were detected with anti-myc and anti-HA antisera;
expected sizes of the epitope tagged proteins are indicated.
proteins likely to constitute the putative T. brucei ORC are
highly diverged in sequence (see below) from the canonical
six ORC subunits found in yeast, mammals andDrosophila,
each of which belongs to the opisthokont eukaryote super-
group (48). As a result, it remains possible that T. brucei
ORC may not comprise the expected six subunits. In this
regard, we show that TbORC1B is not a static component
of T. brucei ORC, since its expression and/or nuclear local-
ization is, uniquely among the T. brucei replication factors
examined to date, limited to S phase. Thus, ORC architec-
ture and regulation appear to be diverged features of repli-
cation initiation in T. brucei.
Is TbORC1B a positive regulator of T. brucei nuclear DNA
replication?
TbORC1B was initially identified as a second Orc1-
like protein in T. brucei (56) and has been proposed
to be a putative T. brucei ORC subunit (82,83). Super-
resolution microscopy suggests that TbORC1B-12myc,
TbORC1/CDC6–12myc and TbORC4–12myc all display
related punctate localization throughout the nucleus. These
findings may argue that TbORC1B is recruited to the pu-
tative ORC once in the nucleus. However, the same lo-
calization studies indicate that TbORC1B is not a static
ORC subunit and may act instead as a positive regula-
tor of T. brucei replication. Unlike the myc-tagged ver-
sions of TbORC1/CDC6, TbORC4, Tb7980 and Tb3120,
TbORC1B-12myc is detectable in the nucleus of only∼33%
of the cells in an asynchronous population, being limited
to S phase cells. A cell cycle transcriptome study (84) sug-
gests that TbORC1BmRNA levels vary, peaking in late G1
and then reducing through S phase and G2 phases. Though
these data may indicate mRNA turnover contributes to
TbORC1B expression changes, the absence of detectable
protein in early-mid G1 cells suggest that further, post-
translational controls also operate. Although TbORC1B
has been reported to interact with TbORC1/CDC6 dur-
ing immunoprecipitation (56), reproducing this finding us-
ing a different combination of epitope tags has proved
problematic (data not shown). Additionally, TbORC1B has
not been recovered from IP-mass spectrometry analysis of
TbORC1/CDC6–12myc or TbORC4–12myc, and the same
analysis of TbORC1B-12myc does not recover any putative
ORC component (data not shown). Taken together, these
findings are consistent with the suggestion that any inter-
action between TbORC1B and the other ORC-like factors
may be transitory or unstable, although it is possible that the
limited expression of TbORC1B during the cell cycle makes
detection of such interactions challenging.
The effects of TbORC1B expression silencing by in-
ducible RNAi in PCF cells arise at least twice as quickly as
those seen for TbORC1/CDC6 and TbORC4 (though are
comparable in outcome). S phase limitation of TbORC1B
expression most likely explains the rapidity and nature of
the phenotypes seen after RNAi induction. At 6 h post-
RNAi induction, no clear cell cycle perturbations are ob-
served by DAPI staining, although flow cytometry analy-
sis suggests a decrease in the number of G2/M phase (4n)
cells. At the same time point, an ∼60% reduction in nuclear
EdU incorporation is seen, suggesting that RNAi against
TbORC1B impedes replication within a single PCF cell cy-
cle (population doubling ∼12 h). In an asynchronous cell
culture, the majority of T. brucei cells are in G1 (∼78%),
when TbORC1B is not expressed. Thus, upon TbORC1B
RNAi-induction, most cells will fail to express TbORC1B
as they enter S phase, explaining why EdU incorporation
is nearly undetectable 12 h after RNAi induction. The con-
comitant increase of cells that are morphologically 1N2K,
but with unreplicated nuclei, is consistent with T. brucei
kinetoplast and nuclear S phases being independent (73,85),
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indicating that loss of TbORC1B does not prevent the
cells from continuing to replicate and segregate their mi-
tochondrial genome. As RNAi induction progresses, both
for TbORC1B and the other factors, the accumulation of
0N1K (zoid) cells is consistent with previous data (86),
which showed that cytokinesis can occur in the absence of
successful mitosis in PCF cells. Though the accumulation of
aberrant cells, indicative of cell cycle alterations, is seen after
RNAi of many essential factors, it is not a universal pheno-
typic response in these circumstances (65). The distinct cell
cycle phenotypes seen after TbORC1B or TbORC1/CDC6
RNAi in BSF T. brucei cells, which are characterized not
by the formation of zoids but frequently by multinucleate
and multikinetoplast cells, seem most simply explained by
the rapid activation of a cytokinesis cell cycle checkpoint in
this life cycle stage.
The pattern of expression and localization of TbORC1B
cannot be readily compared with any characterised pre-RC
replication factor in other eukaryotes. Though TbORC1B
was described as Orc1-like, the size and predicted domain
composition of the polypeptide are perhaps more compa-
rable with Cdc6 (87); indeed, protein BLAST searches with
TbORC1B as query mainly recover Cdc6 sequences (data
not shown). This may be telling, because Cdc6 expression
and subcellular localization have been shown to be cell cy-
cle regulated in many eukaryotes. Pre-RC assembly on ori-
gins, mediated by Cdc6, is conventionally considered to oc-
cur from late mitosis through G1. Upon entering S phase
origins are activated and re-replication is prevented by some
pre-RC disassembly, frequently by changes in Cdc6 local-
ization or abundance. For instance, mammalian Cdc6 lo-
calizes to the nucleus in G1 phase and is transferred to
the cytoplasm as the cell enters S phase (88,89). In S. cere-
visiae and S. pombe, Cdc6 transcription is limited to M–G1
phases and the protein is degraded as the yeast cells enter
S phase (90,91) via ubiquitylation and proteasome target-
ing (92–95). Thus, despite the potential sequence homology,
TbORC1B’s behaviour is quite unlike Cdc6. In addition,
whether or not TbORC1B possesses ATPase activity, a cen-
tral means by which Cdc6 exerts its activity is unclear (56).
Regulation of the activity of ORC has also been reported
in eukaryotes, including Orc1. In mammals, Orc1 has been
shown to undergo selective degradation (96) and nuclear ex-
clusion (97), but again these processes occur during S phase
(98), and therefore differ from the S phase nuclear accumu-
lation we see for TbORC1B. The closest analogy between
TbORC1B expression dynamics and ORC in any other eu-
karyote is with ORC1 of D. melanogaster. In the fly, ORC1
is detectably expressed from late G1 phase through S, and is
then degraded in M phase and during G1 by the Anaphase
Promoting Complex through ubiquitin-mediated degrada-
tion guided by signals in the protein’s N-terminus (99,100).
However, mutation of D. melanogaster ORC1 to prevent
M to G1 degradation has no effect on cell cycle progres-
sion, and it has been suggested that ORC1 expression dy-
namics may be needed for cell type-specific gene amplifica-
tion by endoreplication(101,102). There is no evidence that
T. brucei possesses any such discrete replication reactions.
Furthermore, D. melanogaster ORC1 is highly conserved
relative to opisthokont Orc1 subunits, including retention
of an N-terminal BAH domain, and is part of a conven-
tional six subunit ORC (22,35). As TbORC1B is more di-
verged in sequence from Orc1 than TbORC1/CDC6 and
lacks any equivalent N-terminal sequence to that used inD.
melanogaster ORC1 degradation, the analogy with the D.
melanogaster factor, while intriguing, is limited. Instead, it
appears likely that the S phase restriction of TbORC1B is
central to the control of DNA replication in T. brucei.
TbORC1B nuclear localization dynamics are strikingly
similar to T. brucei proliferating cell nuclear antigen
(PCNA) (79), the sliding clamp involved in DNA poly-
merase association with DNA. In T. brucei, though not
in related kinetoplastids (78,103,104), PCNA is only de-
tectable in the nucleus of cells from late G1 phase to late S
phase; indeed, TbPCNA nuclear localization shows similar
large numbers of puncta as seen for TbORC1B, and similar
partial overlap with newly replicated DNA (79). The avail-
able data are consistent with TbORC1B acting as a posi-
tive regulator of T. brucei nuclear DNA replication, since
its dynamic presence in the nucleus correlates with the on-
set of DNA synthesis. If so, this would be a highly unortho-
dox strategy for replication control, and how TbORC1B
might exert such a function is unclear. In other eukary-
otes, interaction between ORC and the MCM helicase is
mediated by Cdt1 (2,16), a factor that bears no sequence
comparison with TbORC1B. Nonetheless, TbORC1B, like
TbORC1/CDC6, has been reported to interact with the
TbMCM helicase subunit TbMCM3 (56). In this regard,
the potential that T. brucei ORC and MCM interact rather
stably (see below) might indicate that TbORC1B acts in an
unprecedentedway to influence the dynamics of pre-RC for-
mation or regulation in the parasite.
What is the composition of T. brucei ORC?
Gel filtration analysis shown here indicates that
TbORC1/CDC6 is present, with TbORC4, in a high
molecular weight complex in PCF cells, providing the first
indication that an ORC-like complex is present in T. brucei.
However, identifying the remaining constituent proteins of
such an ORC has been challenging and therefore its compo-
sition remains to be fully established (Figure 9). To date, we
can place one other factor, along with TbORC1/CDC6 and
TbORC4, in T. brucei ORC with reasonable confidence:
Tb3120. RNAi of each of these three factors results in
impaired DNA replication, in each case leading to related
cell cycle defects in PCF cells. Moreover, each of the three
proteins displays similar punctate nuclear localization
throughout the cell cycle, and each has sequence character-
istics of ATPase function (see below). We suggest that it is
likely that Tb7980 is also an ORC component: though we
could not recover stem-loop RNAi cells to test for loss of
EdU incorporation after knockdown, in previous analysis
loss of the factor resulted in the same cell cycle defects seen
after TbORC1/CDC6, TbORC4 or Tb3120 RNAi (49),
which were shown here to follow from impaired replication.
In addition, Tb7980 has homology to AAA+ ATPases, a
common feature of ORC subunits (see below), and shows
the same constitutive nuclear localization as the three other
T. brucei ORC candidates.
A complexity in understanding T. brucei ORC is the size
of the putative complex in which TbORC1/CDC6 is found
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Figure 9. Potential ORC architecture in T. brucei. Architecture of the D. melanogaster origin recognition complex (ORC; composed of Orc subunits
numbered 1–6), which interacts (arrow) with the Orc1-related factor Cdc6, is shown based on the structure determined by (22). In T. brucei, recognisable
ORC subunit orthologues of Orc1 and Orc4 (TbORC1/CDC6 and TbORC4, respectively) are identified using the same colours and solid outlines, while
putative orthologues of Orc2 and Orc5 (Tb3120 and Tb7980, respectively) are shown by dotted circles and lighter colours; subunits that are absent or
highly diverged are shown by unfilled dotted circles. TbORC1B interacts with TbORC1/CDC6, but appears to not be a static ORC component, and hence
its inclusion in ORC is uncertain.
(greater than 530 kDa and perhaps as large as 1334 kDa,
from gel filtration): this is too large to be composed of only
TbORC1/CDC6, TbORC4, Tb7980 and Tb3120, which
would be∼305 kDa (assuming each protein interacts in sin-
gle copy). It seems unlikely that TbORC1B interacts stably
with the putative ORC, but even if it did, the size of the pre-
dicted complex would only be ∼371 kDa. One explanation
for this dichotomy is that the TbORC1/CDC6 immunopre-
cipitations conducted to date (49,56) have failed to recover
furtherT. bruceiORCcomponents that are present and have
escaped sequence-based identification (Figure 9). However,
perhaps the most likely explanation for the large size of
the TbORC1/CDC6-containing complex is revealed by the
demonstration at least some of TbMCM3 and TbORC4 co-
elute with TbORC1/CDC6. These data suggest the com-
plex identified by gel filtration could be the T. brucei pre-
RC, composed of ORC bound to the T. brucei MCM2–7
helicase, which would amount to ∼857 or ∼923 kDa (with-
out or with TbORC1B, respectively). However, this size es-
timate is consistent only with the presence of a single copy
of the TbMCM2–7 hexamer, whereas in vitro studies have
shown that dimers of MCM2–7 associate with ORC in the
pre-RC (105). Thus, whether the complex we detect repre-
sents a ‘true’ pre-RC awaits further analysis.
Why might ORC in kinetoplastids be diverged?
The organisation of the six core subunits (Orcs1–6) of ORC,
and their association with Cdc6, MCM2–7 and Cdt1 in
the pre-RC, has been revealed by EM and crystallographic
studies of the complexes from S. cerevisiae (11,32–34) and
D. melanogaster (22,35). However, it remains unclear what
role is played by each ORC subunit, in particular why six
stably interacting factors are needed to mediate DNA in-
teraction and pre-RC formation. In fact, it is increasingly
clear that the canonical six-subunit ORC, as detailed in
the opisthokonts, is less well conserved in other eukary-
otic groupings, with several of the Orc subunits being un-
detectable through sequence homology (48,49). Irrespec-
tive of whether these data indicate that some ORC com-
ponents have been dispensed with, have substantially di-
verged in sequence, or have even been supplanted by other
factors, variant ORC architecture provides insight into core
ORC functions and lineage-specific adaptations. The data
we present probes ORC architecture in T. brucei, an eu-
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karyote belonging to the excavata supergroup, which may
have diverged from the opisthokonts ∼1 billion years ago
(106). From these data, what ORC features are conserved
and diverged, and what might these differences reveal? As-
suming a T. brucei ORC structure comparable with D.
melanogaster (22), TbORC1/CDC6 and TbORC4 repre-
sent the conserved core of ORC (Figure 9), consistent with
the Drosophila orthologues of these factors being adja-
cent in the complex and evidence for functional interac-
tion through shared ATPase motifs (22,107). In this regard,
it is notable that TbORC1/CDC6 and TbORC4 are the
only two T. brucei ORC factors that display clear, primary
sequence-derived orthology with characterised ORC sub-
units in other eukaryotes (49), albeit with TbORC1/CDC6
(and orthologues in other kinetoplastids) lacking an N-
terminal BAH domain, which is conserved in all other stud-
ied eukaryotes. In the light of the recently solved structure
of D. melanogaster ORC (22), we tentatively propose that
Tb3120 is related to Orc2: though eukaryotic ORC factors
are not recovered in BLASTp searches using Tb3120 as a
query, structural modelling predicts that D. melanogaster
Orc2 and Tb3120 are related in their C-termini, a region in-
cluding theOrc2WHdomain (Supplementary Figure S11A
and B). In addition, though there is no evidence for an
intact AAA+ ATPase domain in Tb3120, non-canonical
Walker A and Walker B motifs, which possess sequence
patterns characteristic of Orc2 proteins (33), can be iden-
tified (Supplementary Figure S11C). Indeed, these motifs
lie within two regions of Tb3120, separated by 258 aa,
that display weak evidence of Orc2 domain homology in
Pfam searches (Supplementary Figure S11A). Nonetheless,
Tb3120 (as well as its T. cruzi and L. major counterparts)
remains strikingly large compared with other Orc2 subunits
(1018 residues, compared with ∼580–620 in opisthokonts),
most likely because the kinetoplastid proteins have evolved
anN-terminal extension and an intra-AAA+ATPase inser-
tion (Supplementary Figure S11A), for reasons that have
not been tested. Primary sequence homology searches re-
veal no ORC subunit orthology for Tb7980 (49), but do re-
veal AAA+ ATPase homology at the N-terminus (Supple-
mentary Figure S12A). Structural modelling now suggests
extended homology between Tb7980 and D. melanogaster
Orc5 (Supplementary Figure S12A and B), including align-
ment of theWalker A andWalker B motifs (Supplementary
Figure S12C). This tentative identity for Tb7980 as Orc5
would be consistent with the order of subunit interactions
in D. melanogaster ORC (22), placing Tb7980 adjacent to
TbORC4 in theT. bruceiORC (Figure 9). If this proposedT.
brucei ORC-like organisation is accurate, it suggests a rela-
tively well-conserved Orc1-Orc4 core, with increasing diver-
gence as the complex extends to Orc5 (Tb7980) and Orc2
(Tb3120). Whether T. brucei ORC possesses six subunits,
with even greater subunit divergence beyond Orc1–4–5–2,
or whether subunits equivalent to Orc3 and Orc6 are absent
in T. brucei, is currently unknown. Nonetheless, this topo-
logical organization reflects eukaryote-wide predictions of
ORC presence and absence (48,49) and concurs with some
predictions of ORC composition in the last common eu-
karyotic ancestor (48).
ORC provides at least two functions in DNA replication:
interaction with origins and recruitment of the MCM heli-
case in the pre-RC. Either of these functions could explain
the divergence of T. brucei ORC. DNA binding in eukay-
otic ORCs displays considerable variation, with sequence
specific binding by S. cerevisiae ORC (18) and apparently
sequence-independent DNA interactions by ORC in D.
melanogaster and mammals (108,109). Though to some ex-
tent diverged from archaeal Orc1/Cdc6 DNA interaction
(23), the crystal structure of D. melanogaster ORC suggests
that the WH domains that are common to Orcs1–5 con-
tribute to DNA binding (22). In T. brucei, TbORC1/CDC6
binding sites localize to the boundaries of the RNA Pol
II multigenic transcription units in the core genome, with
a preference for the transcription start sites but without
detectable sequence specificity (55). Sequence features of
typical eukaryotic RNA pol II promoters are lacking in
the parasite genome, and transcription initiation may rely
on lineage-specific chromatin cues (110). In this light, the
absence of a BAH domain in TbORC1/CDC6, or in any
presently identified interacting partner, is striking, since
this feature contributes to origin selection in opisthokonts
(111,112). More broadly, the variant architecture of kineto-
plastid ORCmay also reflect lineage-specific adaptations in
how the complex interacts with the genome, perhaps due to
binding to variant transcription machinery or chromatin.
Indeed, variation in this key step of origin designation may
be widespread, since the ORC of T. thermophila can re-
cruit an rRNA species for DNA binding (113,114). Struc-
tural data suggest that ORC in both S. cerevisiae and D.
melanogaster undergoes substantial reorganisation on bind-
ing Cdc6 and throughATP hydrolysis, which allows recruit-
ment of Cdt1-MCM2–7, again potentially through ORC
WHdomains (11,22,32). Towhat extent such changesmight
be altered in T. brucei ORC if some subunits are absent
or have been replaced by factors lacking AAA+ ATPase
domains (thereby limiting oligomerization or inter-subunit
motif interactions, which are typical of AAA+ATPases) (4)
is hard to evaluate in the absence of structural data. How-
ever, it may indicate a change in the nature or dynamics
of T. brucei ORC interaction with the replicative helicase,
perhaps consistent with the observation that at least one
subunit of what appears to be a typical MCM2–7 hexamer
(49,56)may interact in a complexwithTbORC1/CDC6 and
TbORC4. Indeed, the diverged ORC architecture might be
related to how the variant, positive acting role of TbORC1B
influences pre-RC assembly or regulation during T. brucei
nuclear DNA replication.
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